Eu Yan Sang Q2 net falls 31% on interest expense, taxes
But CEO Richard Eu points to strong operating profit growth
HIGHER interest costs and taxes caused traditional Chinese medicine (TCM) retailer Eu Yan Sang to post a 31 per cent decline in its net profit to $3.2 million for its second quarter ended Dec 31, 2013.
Revenue, however, was up 18 per cent at $91.9 million due to its core retail business growing across most markets, supplemented by strong wholesale performances from Hong Kong and Macau.
Earnings per share for the quarter fell to 0.72 cent from 1.05 cents a year earlier.
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Companies & Markets
DBS customers unable to log into digibank, PayLah! on Thursday
NYSE-parent ICE’s revenue misses as muted IPO markets offset record energy trading
Amazon bets big with CrowdStrike on cybersecurity products
Goldman Sachs scraps EU-era bonus cap for top bankers in UK: source
Thomson Reuters lifts 2024 forecast on first quarter revenue result
US: Wall St opens higher after Fed leaves interest rates alone